Abbott Laboratories buy Barclays PLC
Start price
22.04.24
/
50%
€100.82
Target price
22.04.25
€131.54
Performance (%)
1.65%
Price
30.08.24
€102.48
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC shows slight gains of 1.65%. This prediction currently runs until 22.04.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Abbott Laboratories | 1.788% | 1.788% |
iShares Core DAX® | 1.560% | 2.566% |
iShares Nasdaq 100 | 0.517% | 1.894% |
iShares Nikkei 225® | 1.730% | 5.631% |
iShares S&P 500 | 1.482% | 1.594% |
Comments by Barclays_PLC for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Barclays PLC from $141.00 to $140.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Barclays_PLC for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€96.39
29.07.24
29.07.24
€132.17
29.07.25
29.07.25
6.32%
30.08.24
30.08.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€103.14
26.01.24
26.01.24
€129.82
26.01.25
26.01.25
-0.14%
30.08.24
30.08.24